Every New York stock exchange trading day I’m posting a daily dividend stock or fund review. I’ll share the three chief qualities of just one equity or fund that could be selected for a dividend stock portfolio I’ve named the Safari to Sweet Success.
This week my Safari portfolio seeks a company in the healthcare sector.
That sector includes ten industries all related to testing, diagnosing and treating what ails us. The healthcare industries are: biotechnology; diagnostics & research; drug manufacturers – major; drug manufacturers – specialty & generic; healthcare plans; long-term care facilities; medical care; medical devices, medical distribution; medical supplies.
Today I’m reviewing a medical device company, Sonova Holding AG. Its trading ticker symbol is SONVY.
Sonova Holding AG develops and sells technologically advanced hearing systems for adults and children.
The company operates in the Americas, Europe, the Middle East, Africa, and Asia, offering its products through a proprietary sales and distribution network, of about 50 wholesale companies and 100 independent distributors, and the AudioNova retail network of approximately 3,300 locations in 12 markets.
The company was formerly known as Phonak Holding AG and changed its name to Sonova in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
I use three primary keys to gauge dividend equities or funds like Sonova Holding AG (SONVY):
(1) Price
(2) Dividends
(3) Returns
SONVY Price
Sonova Holding’s price at yesterday’s market close was $31.01 per share.A year ago its price was $25.88. Thus, it gained$5.13 per share in the past year.
If SONVY does as well this coming year its value will increase from $31.01 to $36.14, or about 16.6%.
SNOVY Dividends
Sonova Holding’s most recent annual dividend was $0.47 declared May 13th and paid July 5th, 2017.
